2-t-Butyl-5-pivaloylthiophen | 71951-48-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-t-Butyl-5-pivaloylthiophen
• 英文别名: 1-(5-Tert-butylthiophen-2-yl)-2,2-dimethylpropan-1-one
• CAS: 71951-48-9
• 化学式: C₁₃H₂₀OS
• 分子量: 224.367
• InChiKey: OZNUGFZMSJAHRC-UHFFFAOYSA-N

物化性质

• 沸点：
  292.0±20.0 °C(Predicted)
• 密度：
  0.989±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  45.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-t-Butyl-5-pivaloylthiophen 生成 2-tert.-Butyl-5-pivaloyl-2,5-dihydrothiophen
  参考文献：
  名称：

  NISHINO K.; YANO S.; KOHASHI Y.; YAMAMOTO K.; MURATA I., J. AMER. CHEM., SOC., 1979, 101, NO 17, 5059-5060

  摘要：

  DOI：
• 作为产物：
  描述：

  三甲基乙酰氯 、 2-叔丁基噻吩 、 四氯化锡 以94%的产率得到
  参考文献：
  名称：

  MURATA I.; NISHINO K.; YANO S.; KOHASHI Y.; YAMAMOTO K., CROAT. CHEM. ACTA, 1980, 53, NO 4, 615-623

  摘要：

  DOI：

文献信息

• Human androgen receptor DNA-binding domain (DBD) compounds as therapeutics and methods for their use
  申请人：The University of British Columbia

  公开号：US10011573B2

  公开（公告）日：2018-07-03

  A compound having the structure of Formula I, wherein A is a substituted or unsubstituted aryl or heteroaryl group, D is a substituted or unsubstituted 5- or 6-membered heteroaryl or heterocyclyl group and E is a substituted or unsubstituted aryl, heteroaryl, cycloalkyl or heterocyclyl group. The compounds are used for the treatment of androgen modulated indications including cancer (prostate, breast, ovarian, endometrial or bladder cancer), hair loss, acne, hirsutism, ovarian cysts, polycystic ovary disease, precocious puberty and age related macular degeneration. The use of the compounds for the manufacture of a medicament for modulating AR activity, a method of treatment using such compounds and a pharmaceutical composition and a commercial package comprising said compounds are also described.

  具有式 I 结构的化合物，其中 A 是取代或未取代的芳基或杂芳基，D 是取代或未取代的 5 或 6 元杂芳基或杂环基，E 是取代或未取代的芳基、杂芳基、环烷基或杂环基。这些化合物可用于治疗雄激素调节适应症，包括癌症（前列腺癌、乳腺癌、卵巢癌、子宫内膜癌或膀胱癌）、脱发、痤疮、多毛症、卵巢囊肿、多囊卵巢病、性早熟和老年性黄斑变性。此外，还描述了这些化合物在制造调节 AR 活性的药物中的用途、使用这些化合物的治疗方法以及包含上述化合物的药物组合物和商业包装。
• Monocyclic thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of same
  申请人：Duquesne University of the Holy Spirit

  公开号：US11078214B2

  公开（公告）日：2021-08-03

  The present invention provides a compound of Formula XXVII: wherein X is CH2 or O, and R1 is H or CH3; or a salt or a hydrate of the compound, and further provides a pharmaceutical composition comprising the compound of Formula XXVII and one or more acceptable pharmaceutical carriers. A method of treating a patient having cancer comprising administering a therapeutically effective amount of a compound of Formula XXVII, or a pharmaceutical composition comprising a compound of Formula XXVII and one or more acceptable pharmaceutical carriers to the patient is disclosed.

  本发明提供了一种式 XXVII 的化合物： 其中X为CH2或O，R1为H或CH3；或该化合物的盐或水合物，并进一步提供了一种药物组合物，该组合物包含式XXVII化合物和一种或多种可接受的药物载体。本发明公开了一种治疗癌症患者的方法，包括向患者施用治疗有效量的式XXVII化合物或包含式XXVII化合物和一种或多种可接受的药物载体的药物组合物。
• METHODS OF ANALYZING POLYNUCLEOTIDES EMPLOYING ENERGY TRANSFER DYES
  申请人：Lee G. Linda

  公开号：US20070154925A1

  公开（公告）日：2007-07-05

  Novel linkers for linking a donor dye to an acceptor dye in an energy transfer fluorescent dye are provided. These linkers faciliate the efficient transfer of energy between a donor and acceptor dye in an energy transfer dye. One of these linkers for linking a donor dye to an acceptor dye in an energy transfer fluorescent dye has the general structure R 21 Z 1 C(O)R 22 R 28 where R 21 is a C 1-5 alkyl attached to the donor dye, C(O) is a carbonyl group, Z 1 is either NH, sulfur or oxygen, R 22 is a substituent which includes an alkene, diene, alkyne, a five and six membered ring having at least one unsaturated bond or a fused ring structure which is attached to the carbonyl carbon, and R 28 includes a functional group which attaches the linker to the acceptor dye.
• ENERGY TRANSFER DYES WITH ENHANCED FLUORESCENCE
  申请人：Lee G. Linda

  公开号：US20070154927A1

  公开（公告）日：2007-07-05

  Novel linkers for linking a donor dye to an acceptor dye in an energy transfer fluorescent dye are provided. These linkers faciliate the efficient transfer of energy between a donor and acceptor dye in an energy transfer dye. One of these linkers for linking a donor dye to an acceptor dye in an energy transfer fluorescent dye has the general structure R 21 Z 1 C(O)R 22 R 28 where R 21 is a C 1-5 alkyl attached to the donor dye, C(O) is a carbonyl group, Z 1 is either NH, sulfur or oxygen, R 22 is a substituent which includes an alkene, diene, alkyne, a five and six membered ring having at least one unsaturated bond or a fused ring structure which is attached to the carbonyl carbon, and R 28 includes a functional group which attaches the linker to the acceptor dye.
• OLIGONUCLEOTIDES AND ANALOGS LABELED WITH ENERGY TRANSFER DYES
  申请人：Lee G. Linda

  公开号：US20070161027A1

  公开（公告）日：2007-07-12

  Novel linkers for linking a donor dye to an acceptor dye in an energy transfer fluorescent dye are provided. These linkers faciliate the efficient transfer of energy between a donor and acceptor dye in an energy transfer dye. One of these linkers for linking a donor dye to an acceptor dye in an energy transfer fluorescent dye has the general structure R 21 Z 1 C(O)R 22 R 28 where R 21 is a C 1-5 alkyl attached to the donor dye, C(O) is a carbonyl group, Z 1 is either NH, sulfur or oxygen, R 22 is a substituent which includes an alkene, diene, alkyne, a five and six membered ring having at least one unsaturated bond or a fused ring structure which is attached to the carbonyl carbon, and R 28 includes a functional group which attaches the linker to the acceptor dye.